Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Century Therapeutics Inc | 2.24m | -136.67m | 276.77m | 152.00 | -- | 1.39 | -- | 123.84 | -2.30 | -2.30 | 0.0377 | 3.06 | 0.0053 | -- | -- | 14,703.95 | -32.26 | -- | -34.19 | -- | -- | -- | -6,115.12 | -- | -- | -- | 0.00 | -- | -57.01 | -- | -4.38 | -- | -- | -- |
Compass Therapeutics Inc. | 0.00 | -42.49m | 282.06m | 32.00 | -- | 1.76 | -- | -- | -0.3343 | -0.3343 | 0.00 | 1.16 | 0.00 | -- | -- | 0.00 | -23.84 | -41.75 | -25.56 | -46.41 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.33 | -- | -56.91 | -- |
Xeris Biopharma Holdings Inc | 163.91m | -62.26m | 286.53m | 377.00 | -- | -- | -- | 1.75 | -0.4525 | -0.4525 | 1.19 | -0.0491 | 0.4914 | 0.9012 | 4.68 | 434,785.20 | -18.66 | -43.60 | -24.99 | -56.57 | 82.52 | 78.23 | -37.98 | -143.08 | 1.23 | -2.01 | 1.04 | -- | 48.68 | 131.50 | 34.23 | -- | 8.43 | -- |
Poseida Therapeutics Inc | 64.70m | -123.43m | 297.19m | 330.00 | -- | 2.84 | -- | 4.59 | -1.38 | -1.38 | 0.7175 | 1.08 | 0.2068 | -- | 7.15 | 196,069.70 | -39.45 | -40.70 | -49.32 | -47.72 | -- | -- | -190.76 | -233.49 | -- | -14.93 | 0.361 | -- | -50.42 | -- | -92.85 | -- | 19.01 | -- |
Verastem Inc | 0.00 | -87.37m | 298.99m | 73.00 | -- | 5.21 | -- | -- | -4.07 | -4.07 | 0.00 | 3.11 | 0.00 | -- | -- | 0.00 | -71.39 | -62.70 | -88.82 | -75.18 | -- | -- | -- | -406.17 | -- | -- | 0.3379 | -- | -100.00 | -- | -18.36 | -- | -- | -- |
Fennec Pharmaceuticals Inc | 13.05m | -20.22m | 299.74m | 36.00 | -- | -- | -- | 22.97 | -0.7598 | -0.7598 | 0.4907 | -0.3954 | 0.5279 | -- | -- | 362,555.60 | -81.79 | -69.00 | -94.92 | -76.08 | 94.94 | -- | -154.92 | -4,799.53 | 4.39 | -5.46 | 1.73 | -- | -- | -- | -36.71 | -- | -- | -- |
Petro Usa Inc | 0.00 | -33.38k | 300.20m | -- | -- | -- | -- | -- | -0.0002 | -0.0002 | 0.00 | -0.0008 | 0.00 | -- | -- | -- | -19,074.29 | -192,120.00 | -- | -- | -- | -- | -- | -- | -- | -118.21 | -- | -- | -- | -- | -81.58 | -- | -- | -- |
AC Immune SA | 16.38m | -60.01m | 300.57m | 133.00 | -- | 1.69 | -- | 18.35 | -0.7102 | -0.7102 | 0.1929 | 1.79 | 0.0803 | -- | 1.92 | 123,144.50 | -29.41 | -18.25 | -31.56 | -19.52 | -- | -- | -366.41 | -148.29 | -- | -89.52 | 0.0213 | -- | 276.14 | 15.52 | 23.35 | -- | -15.49 | -- |
Adverum Biotechnologies Inc | 3.60m | -117.17m | 304.27m | 121.00 | -- | 1.78 | -- | 84.52 | -11.62 | -11.62 | 0.3571 | 8.23 | 0.015 | -- | -- | 29,752.07 | -48.68 | -36.39 | -55.24 | -39.04 | -- | -- | -3,254.58 | -5,279.60 | -- | -- | 0.00 | -- | -- | 17.43 | 24.18 | -- | -0.0247 | -- |
Inovio Pharmaceuticals Inc | 832.01k | -135.12m | 304.52m | 122.00 | -- | 2.53 | -- | 366.00 | -6.12 | -6.12 | 0.0375 | 5.15 | 0.0032 | -- | 0.9778 | 6,819.75 | -52.02 | -59.52 | -71.11 | -71.29 | -- | -- | -16,239.87 | -4,097.36 | -- | -- | 0.125 | -- | -91.89 | -51.33 | 51.71 | -- | -31.22 | -- |
Sutro Biopharma Inc | 153.73m | -106.79m | 307.84m | 302.00 | -- | 2.01 | -- | 2.00 | -1.79 | -1.79 | 2.56 | 2.45 | 0.3503 | -- | 7.12 | 509,043.00 | -24.34 | -25.48 | -29.77 | -29.75 | -- | -- | -69.47 | -113.71 | -- | -- | 0.0264 | -- | 126.84 | 31.96 | 10.41 | -- | 22.61 | -- |
Rapt Therapeutics Inc | 0.00 | -116.80m | 310.74m | 131.00 | -- | 2.09 | -- | -- | -3.05 | -3.05 | 0.00 | 4.27 | 0.00 | -- | -- | 0.00 | -53.15 | -46.30 | -57.90 | -49.97 | -- | -- | -- | -3,522.72 | -- | -- | 0.00 | -- | -100.00 | -- | -39.31 | -- | -20.31 | -- |
Erasca Inc | 0.00 | -125.04m | 311.24m | 126.00 | -- | 0.9828 | -- | -- | -0.8327 | -0.8327 | 0.00 | 2.10 | 0.00 | -- | -- | 0.00 | -27.48 | -- | -29.94 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 48.50 | -- | -- | -- |
Procaps Group SA | 414.10m | 52.20m | 313.65m | 5.50k | 5.34 | 7.96 | 4.50 | 0.7574 | 0.5209 | 0.5209 | 4.16 | 0.3491 | 0.854 | 1.87 | 3.38 | 75,290.18 | 10.77 | -- | 19.01 | -- | 55.04 | -- | 12.61 | -- | 0.9861 | -- | 0.8829 | -- | 0.0434 | -- | 142.18 | -- | -- | -- |
Data as of Mar 27 2024. Currency figures normalised to Poseida Therapeutics Inc's reporting currency: US Dollar USD
Holder | Shares | % Held |
---|---|---|
Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 14.32m | 14.98% |
Pentwater Capital Management LPas of 31 Dec 2023 | 5.98m | 6.25% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 4.39m | 4.59% |
SilverArc Capital Management LLCas of 31 Dec 2023 | 3.71m | 3.88% |
The Vanguard Group, Inc.as of 31 Dec 2023 | 2.85m | 2.98% |
Geode Capital Management LLCas of 31 Dec 2023 | 1.52m | 1.59% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 1.38m | 1.44% |
Aisling Capital Management LPas of 31 Dec 2023 | 1.04m | 1.09% |
William Blair Investment Management LLCas of 31 Dec 2023 | 682.74k | 0.71% |
Millennium Management LLCas of 31 Dec 2023 | 592.58k | 0.62% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.